The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...

The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

The FDA has revealed a set of measures designed to increase the availability of biosimilars in the U.S. and in turn reduce ...

The drug, dubbed ianalumab, both depletes B cells and deactivates those remaining, Thomas Grader-Beck, MD, of Johns Hopkins ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...